First-line chemotherapy in advanced intra-abdominal well-differentiated/dedifferentiated liposarcoma: an EORTC Soft Tissue and Bone Sarcoma Group retrospective analysis
BACKGROUND No prospective trial with anthracycline-based chemotherapy has individually assessed response in a well-differentiated (WD)/dedifferentiated (DD) liposarcoma patient cohort. We conducted a retrospective analysis of first-line chemotherapy in liposarcoma of intra-abdominal origin (IA-LPS)...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
13 May 2022
|
| In: |
Cancer
Year: 2022, Jahrgang: 128, Heft: 15, Pages: 2932-2938 |
| ISSN: | 1097-0142 |
| DOI: | 10.1002/cncr.34264 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1002/cncr.34264 Verlag, kostenfrei, Volltext: http://onlinelibrary.wiley.com/doi/abs/10.1002/cncr.34264 
|
| Verfasserangaben: | Silvia Stacchiotti, Winette T.A. Van der Graaf, Roberta G. Sanfilippo, Sandrine I. Marreaud, Winan J. Van Houdt, Ian R. Judson, Alessandro Gronchi, Hans Gelderblom, Saskia Litiere, and Bernd Kasper |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1869367596 | ||
| 003 | DE-627 | ||
| 005 | 20240307082126.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231106s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/cncr.34264 |2 doi | |
| 035 | |a (DE-627)1869367596 | ||
| 035 | |a (DE-599)KXP1869367596 | ||
| 035 | |a (OCoLC)1425216014 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Stacchiotti, Silvia |e VerfasserIn |0 (DE-588)1164087444 |0 (DE-627)1028474644 |0 (DE-576)508363071 |4 aut | |
| 245 | 1 | 0 | |a First-line chemotherapy in advanced intra-abdominal well-differentiated/dedifferentiated liposarcoma |b an EORTC Soft Tissue and Bone Sarcoma Group retrospective analysis |c Silvia Stacchiotti, Winette T.A. Van der Graaf, Roberta G. Sanfilippo, Sandrine I. Marreaud, Winan J. Van Houdt, Ian R. Judson, Alessandro Gronchi, Hans Gelderblom, Saskia Litiere, and Bernd Kasper |
| 264 | 1 | |c 13 May 2022 | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 06.11.2023 | ||
| 520 | |a BACKGROUND No prospective trial with anthracycline-based chemotherapy has individually assessed response in a well-differentiated (WD)/dedifferentiated (DD) liposarcoma patient cohort. We conducted a retrospective analysis of first-line chemotherapy in liposarcoma of intra-abdominal origin (IA-LPS) in patients who had entered the European Organisation for Research and Treatment of Cancer (EORTC)/Soft Tissue and Bone Sarcoma Group (STBSG) trials. METHODS We searched for all adult patients treated with first-line chemotherapy for advanced IA-LPS in the EORTC STBSG phase 2 and 3 trials from 1978. Treatment was aggregated into 5 groups: anthracycline alone, ifosfamide alone, doxorubicin plus ifosfamide (D+IFO), doxorubicin/cyclophosphamide/vincristine/dacarbazine, and “other” (brostallicin, trabectedin). Response was assessed prospectively by Response Evaluation Criteria in Solid Tumors or World Health Organization criteria. Progression-free survival (PFS) and overall survival (OS) were computed by Kaplan-Meier method. RESULTS A total of 109 patients with IA-LPS from 13 trials were identified (104 evaluable for response). Overall, there were 10/109 (9.2%) responders: 3/48 (6.3%) in the anthracycline alone group, 2/15 (13%) in the ifosfamide alone group, and 4/18 (22%) in the D+IFO group. At the 10-month median follow-up (interquartile range, 6-24), the median OS was 19 months (95% CI, 15-21) and median PFS 4 months (95% CI, 3-6). D+IFO achieved a not statistically significant longer median PFS (12 months) and median OS (31 months) than observed with other regimens. Univariate/multivariate analysis did not identify prognostic factors. CONCLUSIONS Cytotoxic chemotherapy, in particular anthracycline alone, had marginal activity in advanced IA-LPS. Ifosfamide-containing regimens showed higher activity, although it was not statistically significant and in a small number of cases, with the combination of doxorubicin and ifosfamide appearing to be the more active regimen available in fit patients. This series provides a benchmark for future trials on new drugs in WD/DD liposarcoma.; | ||
| 650 | 4 | |a anthracycline | |
| 650 | 4 | |a chemotherapy | |
| 650 | 4 | |a doxorubicin | |
| 650 | 4 | |a epirubicin | |
| 650 | 4 | |a ifosfamide | |
| 650 | 4 | |a liposarcoma | |
| 650 | 4 | |a sarcoma | |
| 700 | 1 | |a Van der Graaf, Winette T. A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Sanfilippo, Roberta G. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Marreaud, Sandrine I. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Van Houdt, Winan J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Judson, Ian R. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gronchi, Alessandro |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gelderblom, Hans |e VerfasserIn |4 aut | |
| 700 | 1 | |a Litiere, Saskia |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kasper, Bernd |d 1974- |e VerfasserIn |0 (DE-588)12274764X |0 (DE-627)082130736 |0 (DE-576)29340447X |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cancer |d New York, NY : Wiley-Liss, 1948 |g 128(2022), 15 vom: Aug., Seite 2932-2938 |h Online-Ressource |w (DE-627)271350334 |w (DE-600)1479932-7 |w (DE-576)078590884 |x 1097-0142 |7 nnas |a First-line chemotherapy in advanced intra-abdominal well-differentiated/dedifferentiated liposarcoma an EORTC Soft Tissue and Bone Sarcoma Group retrospective analysis |
| 773 | 1 | 8 | |g volume:128 |g year:2022 |g number:15 |g month:08 |g pages:2932-2938 |g extent:7 |a First-line chemotherapy in advanced intra-abdominal well-differentiated/dedifferentiated liposarcoma an EORTC Soft Tissue and Bone Sarcoma Group retrospective analysis |
| 856 | 4 | 0 | |u https://doi.org/10.1002/cncr.34264 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u http://onlinelibrary.wiley.com/doi/abs/10.1002/cncr.34264 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20231106 | ||
| 993 | |a Article | ||
| 994 | |a 2022 | ||
| 998 | |g 12274764X |a Kasper, Bernd |m 12274764X:Kasper, Bernd |d 60000 |e 60000PK12274764X |k 0/60000/ |p 10 |y j | ||
| 999 | |a KXP-PPN1869367596 |e 4402603161 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"id":{"doi":["10.1002/cncr.34264"],"eki":["1869367596"]},"recId":"1869367596","relHost":[{"note":["Gesehen am 06.12.2011"],"title":[{"title":"Cancer","title_sort":"Cancer","subtitle":"interdisciplinary international journal of the American Cancer Society"}],"pubHistory":["1.1948 -"],"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"publisher":"Wiley-Liss","dateIssuedDisp":"1948-","publisherPlace":"New York, NY","dateIssuedKey":"1948"}],"titleAlt":[{"title":"Cancer cytopathology"}],"physDesc":[{"extent":"Online-Ressource"}],"disp":"First-line chemotherapy in advanced intra-abdominal well-differentiated/dedifferentiated liposarcoma an EORTC Soft Tissue and Bone Sarcoma Group retrospective analysisCancer","part":{"text":"128(2022), 15 vom: Aug., Seite 2932-2938","issue":"15","year":"2022","extent":"7","pages":"2932-2938","volume":"128"},"language":["eng"],"id":{"doi":["10.1002/(ISSN)1097-0142"],"issn":["1097-0142"],"zdb":["1479932-7"],"eki":["271350334"]},"recId":"271350334"}],"name":{"displayForm":["Silvia Stacchiotti, Winette T.A. Van der Graaf, Roberta G. Sanfilippo, Sandrine I. Marreaud, Winan J. Van Houdt, Ian R. Judson, Alessandro Gronchi, Hans Gelderblom, Saskia Litiere, and Bernd Kasper"]},"physDesc":[{"extent":"7 S."}],"language":["eng"],"title":[{"title":"First-line chemotherapy in advanced intra-abdominal well-differentiated/dedifferentiated liposarcoma","subtitle":"an EORTC Soft Tissue and Bone Sarcoma Group retrospective analysis","title_sort":"First-line chemotherapy in advanced intra-abdominal well-differentiated/dedifferentiated liposarcoma"}],"person":[{"role":"aut","display":"Stacchiotti, Silvia","given":"Silvia","family":"Stacchiotti"},{"role":"aut","display":"Van der Graaf, Winette T. A.","family":"Van der Graaf","given":"Winette T. A."},{"role":"aut","display":"Sanfilippo, Roberta G.","given":"Roberta G.","family":"Sanfilippo"},{"given":"Sandrine I.","family":"Marreaud","display":"Marreaud, Sandrine I.","role":"aut"},{"family":"Van Houdt","given":"Winan J.","display":"Van Houdt, Winan J.","role":"aut"},{"display":"Judson, Ian R.","given":"Ian R.","family":"Judson","role":"aut"},{"family":"Gronchi","given":"Alessandro","display":"Gronchi, Alessandro","role":"aut"},{"family":"Gelderblom","given":"Hans","display":"Gelderblom, Hans","role":"aut"},{"family":"Litiere","given":"Saskia","display":"Litiere, Saskia","role":"aut"},{"role":"aut","family":"Kasper","given":"Bernd","display":"Kasper, Bernd"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedKey":"2022","dateIssuedDisp":"13 May 2022"}],"note":["Gesehen am 06.11.2023"]} | ||
| SRT | |a STACCHIOTTFIRSTLINEC1320 | ||